Replies to post #281783 on Anavex Life Sciences Corp (AVXL)

[frrol]

We got a PR that some felt didn't fully match the subsequent limited results revealed at CTAD. And if RS results are good, the share price will rise again.

[tootalljones]

ya gotta be a real investor....what did friday do, what did the traders do, knock a lousy 100 million off the market cap? everybody was lined up to dump and to trade this ticker, as they have made this a boutique industry the past 4 years....

but the company continues to prove out the drug....that is the truth.

day to day is nothing, you will see.....these results will get air.
skeptics never make real money, that is a truth take to the bank.

the naysayers will point out little smart observations, so very smart of them.

the trial proved out unreal future for 2-73...that is the larger takeaway and Missling knows it and so do the docs he had in the company PR.

Probably. ......the stock market is always about probably......if not, go to bonds and gold and a savings account.

can you imagine the run up that our drug will receive prior to the meeting that biogen just flunked?..and they had a piece of sheat hustle slop drug and it still went crazy.......avxl share price 75, for parkinsons alone, and then you can take profits, on half

[pcguy]

In my non-expert opinion, these were not great results without more information. I think there are too many statistical variables to understand what the results represent. I am not questioning if the results were what they were in these specific measures, only that without all of the information, the data presented has no context.

There have been clinical trials that show great results in some aspect, but there are other aspects that defeat the purpose of the same drug. Some companies are not able to isolate the observed benefit from those that are negative. When something is not presented in full context it leaves question about what was not revealed, and the risk remains. Hope and trust in the unknown are not a good investment strategy, at least in my opinion.

[abew4me]

Very simple answer:

PDD Phase 2 results were excellent...but it was a Phase 2 trial. (FDA will most likely require a P3 trial before approval)

Rett trial called "EXCELLENCE" is a Phase 2/3 trial...The FDA has already granted them Orphan Drug and Fast Track status. This means that they should get immediate approval if results are great...which would transition Anavex from a clinical-stage biotech company to a full fledged pharmaceutical company.

****************************************************************************************

"The U.S. Food and Drug Administration has granted Anavex-2-73 orphan drug, fast track, and rare pediatric disease designations for the treatment of Rett syndrome. Each designation works to facilitate the development of medications to treat serious conditions and fill an unmet medical need.

Anavex-2-73 also is being explored as a potential therapy for people with Alzheimer’s disease and Parkinson’s disease dementia."

https://rettsyndromenews.com/2020/07/08/first-patient-dosed-excellence-trial-testing-anavex-2-73-children-adolescents-rett-syndrome/

[bas2020]

Orchestrated collusive manipulation, up and down.

[LakeshoreLeo1953]

Depends upon the audience that answers.

You are better off with your own DD as apologies
are no better explanation than I told you so(s).